ACTHREL

Brand name authorized in: United Kingdom United States

Active ingredients

The drug ACTHREL contains one active pharmaceutical ingredient (API):

1 Corticorelin
UNII 56X54T817Q - CORTICORELIN OVINE TRIFLUTATE

Corticorelin results in a rapid and sustained increase of plasma ACTH levels and a near parallel increase of plasma cortisol. In addition corticorelin causes a concomitant and prolonged release of the related proopiomelanocortin peptides β- and γ-lipotropins (β- and γ-LPH) and β-endorphin (β-END).

Read about Corticorelin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
Corticotropin
H Systemic hormonal preparations, excl. Sex hormones and insulins → H01 Pituitary and hypothalamic hormones and analogues → H01A Anterior pituitary lobe hormones and analogues → H01AA ACTH
Discover more medicines within H01AA01

Medication package inserts

Below package inserts are available for further reading:

Title
Type
Country
Structured product labeling (SPL)
US

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
GB
Medicines & Healthcare Products Regulatory Agency
Identifier(s): 326208
US
FDA, National Drug Code
Identifier(s): 55566-0302